At volumes of 100, 50, and 25 l, the sensitivities of the whole-blood coculture were 94.5, 93.6, and 87.3%, respectively. The PBMC culture in the presence of added RBCs was more sensitive than PBMC coculture alone. The citrated whole-blood coculture was simple to perform, produced a reliable diagnosis of HIV infection in adult volunteers, was more sensitive than previously reported techniques even in half the culture time, and showed less variability than the PBMC coculture. Citrated whole-blood coculture may be a useful and efficient tool for diagnosing infection with HIV-1.
Isolation of human immunodeficiency virus type 1 (HIV-1) from peripheral blood mononuclear cells (PBMC) is an accepted standard for diagnosing infection with HIV-1 (11, 16) . The technique requires 5 to 20 ml of blood and is therefore less than ideal for use with infants, young children, and anemic adults (4) . Further, the culture is expensive and time-consuming, because it requires the separation of PBMC from whole blood. These limitations spurred the development of microculture techniques to quantitate the viral load in PBMC and in the plasma of adults and children (1, 4, 10, 17) . While using comparatively smaller volumes of blood, these methods still require isolation of PBMC by centrifugal separation.
Whole-blood culture techniques to isolate HIV-1 use small sample volumes, do not require the centrifugal separation of PBMC from samples, and allow measurement of the total viral burden in the peripheral circulation. Earlier studies using heparinized whole blood mandated 40 days for completed culture and isolated HIV-1 at a rate of only 20% (4) . In other studies, heparinized whole blood was used successfully in an end point dilutional culture method for the diagnosis of vertical transmission of HIV-1 and in the diagnosis of HIV-1 infection in pediatric cases (2) . However, previous research has raised questions about the use of heparin as an anticoagulant when culturing HIV-1 (3, 5) . Heparin is known to interfere with PCR amplification, and it may inhibit the binding of laboratory strains of HIV-1 to target cells in vitro. While the use of EDTA has been investigated as an alternative, the positive culture rate with EDTA was as low as 50% in individuals with T4 counts greater than 400 (5) .
In the present study, we used a whole-blood coculture technique to evaluate the quantification of viral load in HIV-1-infected adults. The method employs citrate as an anticoagulant, uses smaller sample volumes than previously reported techniques, and does not require separation of patients' PBMC. To assess the sensitivity of this method, we compared the results of citrated whole-blood coculture with those obtained by the standard AIDS Clinical Trial Group PBMC semiquantitative culture method (8, 10) and levels of plasma HIV-1 RNA. PBMC cocultures were also set up with exogenous erythrocytes (RBCs) to determine if the presence of RBCs affects the replication of HIV-1 in vitro.
MATERIALS AND METHODS

Volunteers.
The study population consisted of HIV-1-seropositive volunteers from the Johns Hopkins University Moore Clinic (Baltimore, Md.). The patients were between 30 and 50 years of age, with a mean age of 37.2 years. No attempt was made to select the patients by CD4 levels, symptom status, or treatment. A medical history was obtained, and a physical examination was performed before enrollment and at each sampling. The study protocol and the informed consent form were approved by the Joint Committee on Clinical Investigation at the Johns Hopkins University Medical Institutions.
PBMC microculture assay. PBMC coculture was performed according to the standard AIDS Clinical Trial Group protocol (10) . Briefly, PBMC were isolated by Ficoll-Paque density gradient centrifugation (Pharmacia, Piscataway, N.J.) from citrated blood within 4 h of collection from all donors. HIV-1-negative PBMC obtained by Ficoll separation from a Red Cross leukopak were stimulated for 72 h with 5 g of phytohemagglutinin (PHA-P) per ml of RPMI 1640 medium containing 20% heat-inactivated fetal bovine serum, 3% interleukin 2 (IL-2), L-glutamine, and penicillin-streptomycin (100 U/ml-100 mg/ml). Prior to coculture, the PHA-stimulated PBMC were washed and resuspended in RPMI 1640 with 20% heat-inactivated fetal bovine serum, 5% IL-2, L-glutamine, and penicillin-streptomycin.
The cocultures contained 10 6 PHA-stimulated uninfected PBMC along with HIV-1-positive PBMC ranging in number between 1 ϫ 10 6 and 3.2 ϫ 10 2 in serial fivefold dilutions set up in duplicate. The cultures were maintained for 14 days. On day 7, 1 ml of culture supernatant was replaced by fresh culture medium containing 5 ϫ 10 5 PHA-stimulated HIV-1 negative PBMC. Culture supernatant from day 14 was tested for HIV-1 p24 antigen by the viral quantity assessment standardized p24 enzyme immunoassay (ABBOTT, Abbott Park, Ill.) procedure. Retrovirus Laboratory Management Program software (Dataworks, Seattle, Wash.) was used to calculate the viral load, which was expressed as infectious units per million cells.
Whole-blood coculture. Cocultures containing 10 6 HIV-negative PHA-stimulated PBMC were established in 1 ml of medium (RPMI 1640 medium with 10% heat-inactivated fetal bovine serum, 2 U of IL-2, 2 mM L-glutamine, and penicillin-streptomycin (100 U/ml-100 mg/ml) along with citrated whole blood from HIV-1-positive patients added at serial twofold volume reductions of 100, 50, 25, 12.5, and 6.5 l. The samples were set up in quadruplicate. Cultures were maintained for 14 days. The cultures were refed with 0.5 ml of the fresh medium at an interval of 3 to 4 days. Culture supernatants from day 7 were sampled for p24 production by using Vironostica HIV-1 p24 antigen kits according to the manufacturer's instructions (Organon Teknika, Durham, N.C.).
PBMC coculture with RBCs. HIV-1 was cultured from infected PBMC with and without the addition of RBCs from HIV-1-seronegative donors. PBMC coculture with RBCs was previously described (18) . Briefly, HIV-1-negative PBMC were stimulated with PHA (5 g/ml) and IL-2 (2 U/ml) for 72 h and washed before coculture with PBMC from HIV-positive individuals. RBCs, obtained by passing the HIV-1-negative blood through a leukocyte removal filter (RXCL 1; Pall Biomedical, Inc., Fajardo, P.R.), were washed with RPMI 1640 and counted. Cocultures contained 1:5 and 1:10 ratios of infected to uninfected cells and 5 ϫ 10 8 RBCs. Cultures without RBCs were set up as controls. All cultures were refed with 0.5 ml of the fresh medium at an interval of 3 to 4 days. Culture supernatants from day 7 were sampled for p24 production by using Vironostica HIV-1 p24 antigen kits according to the manufacturer's instructions (Organon Teknika).
Plasma HIV-1 RNA measurement. Citrated plasma was stored at Ϫ80°C for batched analysis of HIV-1 RNA (13) Statistical analysis. In both PBMC and whole-blood culture methods, the end point was defined as the mean of the lowest dilutions in which at least 50% of the cultures were p24 positive. The mean number of cells required to isolate HIV-1 from each sample was determined. For PBMC cocultures, the count was obtained by Sysmex Microcell counter (TOA Medical Electronics, Carson, Calif.). This number was then used to estimate the PBMC content of whole blood. In whole-blood coculture, each patient's lymphocyte count/whole-blood volume ratio was calculated. In each sample, this ratio was used to obtain cell counts from known volumes of blood. Student's t test was used to compare differences in the mean number of cells required for positive culture by each method. The sensitivity of the whole-blood culture method was assessed at 100-, 50-, and 25-l volumes and compared with that of PBMC coculture at 1 ϫ 10 6 , 2 ϫ 10 5 , and 4 ϫ 10 4 cells in culture. Data generated from cocultures with and without RBC were analyzed using a chi-square test for matched pairs data. ). According to the two-tailed t test, the cell requirement in the PBMC coculture method was significantly greater than the cell requirement in the whole-blood coculture method (P Ͻ 0.01). Figure 1 shows the mean number of cells required for an HIV-1-positive culture by visit. For the whole-blood coculture, consistently fewer cells were required and the standard error was uniformly narrow. In the PBMC coculture method, the number of cells required for virus isolation was greater, and the standard error was larger and varied widely. At volumes of 100, 50, and 25 l, the sensitivities of the whole-blood coculture method were 94.5, 93.6, and 87.3%, respectively, while the sensitivities of PBMC cocultures at 1 ϫ PBMC and whole-blood culture versus plasma HIV-1 RNA. HIV-1 RNA measurements of plasma from the 55 samples used for PBMC coculture and whole-blood coculture (Table 1 ) revealed no correlation between the level of plasma virions and the number of cells required for a positive PBMC coculture or whole-blood culture. The levels of HIV-1 RNA detected in the plasma samples of individual patients from visit 1 through visit 7 were comparable and relatively stable (less than 0.5-log variation between samples from visits 1 through 7).
RESULTS
PBMC versus whole-blood
DISCUSSION
Early attempts to isolate HIV-1 from heparinized whole blood of infants and children resulted in low isolation rates and poor correlation with PBMC culture results. Most studies did not evaluate coculture in adults (2, 4, 5) . The citrated wholeblood coculture method described employs small blood volumes, is simple to perform, and does not require separation of the blood samples into cellular subsets. The method produced a reliable diagnosis of HIV-1 infection in adult volunteers, was highly sensitive, required only 7 as opposed to 14 days, and showed less variability than the PBMC coculture method. One previous study reported a similar method of heparinized whole-blood culture with a sensitivity of 91.9% (9) . The citrated whole-blood coculture presented here was even more sensitive, even though we used one-fifth the volume of blood. In our PBMC coculture, HIV-1 isolation was facilitated by the addition of RBCs. A chemokine receptor that binds to many of the ␣ and ␤ chemokines has been identified on the surfaces of RBCs (6, 12, 14) . Given the recent identification of antiviral chemokines (7, 15) , the presence of the RBCs in the cocultures may enhance HIV-1 growth by removing the chemokines from the supernatant. Furthermore, infectious HIVantibody-complement complexes may bind to the complement receptors on RBCs and contribute to the whole-blood viral inoculum. The free HIV-1 virions in plasma may contribute only to multiply the higher sensitivity of the whole-blood culture. Studies indicate that less than 1/1,000 plasma virions are infectious in vitro (11) . Given the fact that strong positive cultures were always detected at 6 to 100 l of whole-blood volumes containing ϳ1 to 30 l of plasma, it is unlikely that our volunteers' plasma, generally containing fewer than 10 5 virions/ml, would contribute to positive results.
Efficient use of blood samples avoids repeated needle sticks of HIV-1-infected persons and may permit evaluation of infants, children, and anemic adults. Semiquantitative whole blood culture may be a useful tool in diagnosing HIV-1 infection in newborns and infants, in whom the presence of vertically transmitted maternal antibodies may interfere with the use of currently available diagnostic assays. Additionally, whole-blood coculture may permit recovery of virus strains with different tropisms or greater diversity.
